World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   674 records for 140 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingYesISRCTN16199080
Evaluation of the motivation and key drivers of general practitioners in Belgium and Luxembourg to SIMPLIFY or intensify antihypertensive treatment in uncontrolled hypertensive patients
05/04/2017
Not recruitingYesNCT03101865
The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01)
30/03/2017
Not recruitingYesNCT03115437
Effects of Shoe Cushioning and Body Mass on Injury Risk in Running
30/03/2017
RecruitingYesNCT03103867
QUality of Control and slEep in Children With diabeteS, Using New Technology
26/03/2017
RecruitingYesNCT03052309
BIOLUX P-III BENELUX All-Comers Registry
02/02/2017
AuthorisedYesEUCTR2016-003467-19-GB
safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre / postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2016-003467-19-PTsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease14/12/2016
AuthorisedEUCTR2016-003467-19-ATsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease03/02/2017
AuthorisedEUCTR2016-003467-19-ESSafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease10/02/2017
AuthorisedEUCTR2016-003467-19-NLsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease23/11/2016
AuthorisedEUCTR2016-003467-19-HUsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease25/11/2016
AuthorisedEUCTR2016-003467-19-BGsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease07/12/2016
AuthorisedEUCTR2016-003467-19-GRsafety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease03/01/2017
07/11/2016
RecruitingYesNCT02931955
Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy
03/10/2016
Not recruitingYesNCT02908308
Hypothermia or Normothermia-Targeted Temperature Management After Out-of-hospital Cardiac Arrest-trial
16/09/2016
RecruitingYesNCT02907463
EDWARDS INTUITY Elite Valve System
29/06/2016
RecruitingYesNCT02737501
ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in ALK-positive Advanced Non-Small Cell Lung Cancer Patients
Recruitment statusMain IDPublic titleDate of registration
RecruitingDRKS00011682A Phase 3 Multicenter Open-label Study of Brigatinib (AP26113) Versus Crizotinib in Patients With ALK-positive Advanced Lung Cancer02/02/2017
30/03/2016
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history